相关实验视频
Updated: Jul 26, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.8K
先进的侵入性黑色素瘤的管理:新的策略
Alessia Villani1, Massimiliano Scalvenzi2, Giuseppe Micali3
1Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini, 5, 80131, Naples, Italy. ali.vil@hotmail.it.
Advances in therapy
|June 12, 2023
概括
皮肤黑色素瘤 (CM) 的治疗因阶段而异. 侵袭性黑色素瘤需要个性化,结合的手术和医疗方法,正在研究新的药物,以量身定制的患者护理.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
背景情况:
- 全球皮肤黑色素瘤 (CM) 发病率正在上升.
- 在CM诊断范围从原位黑色素瘤 (表皮) 到侵入性 (皮肤入侵).
- 在现场和侵入性CM之间,治疗策略有很大的不同.
研究的目的:
- 审查有关侵袭性黑色素瘤治疗选择的当前文献.
- 为管理入侵性CM.提供战略方法的概述.
- 为了强调基于瘤阶段的个性化治疗的需要.
主要方法:
- 对当前科学文章的文献评论.
- 对侵袭性黑色素瘤治疗策略的分析.
- 综合有关手术和医疗干预的信息.
主要成果:
- 现场黑色素瘤需要有限的切除.
- 侵袭性黑色素瘤需要个性化,阶段依赖的方法.
- 对于侵袭性形式,通常需要结合手术和医疗治疗.
- 基于黑色素瘤发病因的新兴疗法正在研究中.
结论:
- 侵入性黑色素瘤的有效管理需要广泛的知识.
- 结合手术和医疗治疗的量身定制方法至关重要.
- 对新型药物的持续研究有望改善患者的治疗结果.
相关概念视频
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K

